Principal Investigator
Kevin Gray, MD
Addiction Sciences Division - Medical University of South Carolina
- 2 trials
- 1 compound
Therapeutic focus
- Cannabis Use Disorder
- Marijuana Abuse
- Nicotine Dependence
All trials (2)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT05322941 | Phase 2 | Completed | AEF0117 (lixosicone) | Aelis Farma S.A. |
| NCT00664755 | Phase 2 | Completed | — | Medical University of South Carolina |
Compounds studied
Trial sites (11)
- New York, New York, United States
- Portland, Oregon, United States
- Miami Lakes, Florida, United States
- New Haven, Connecticut, United States
- Charleston, South Carolina, United States
- Garden Grove, California, United States
- San Antonio, Texas, United States
- Los Angeles, California, United States
- Lauderhill, Florida, United States
- Phoenix, Arizona, United States
- Draper, Utah, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).